These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 28181959)

  • 1. Indications for and use of long-acting injectable antipsychotics: consideration from an inpatient setting.
    Kishimoto T; Sanghani S; Russ MJ; Marsh AN; Morris J; Basu S; John M; Kane JM
    Int Clin Psychopharmacol; 2017 May; 32(3):161-168. PubMed ID: 28181959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do Long-Acting Injectable Antipsychotics Prevent or Delay Hospital Readmission?
    Maestri TJ; Mican LM; Rozea H; Barner JC
    Psychopharmacol Bull; 2018 Mar; 48(3):8-15. PubMed ID: 29713100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adherence, health care utilization, and costs between long-acting injectable and oral antipsychotic medications in South Carolina Medicaid beneficiaries with schizophrenia.
    Cai C; Kozma C; Patel C; Benson C; Yunusa I; Zhao P; Reeder G; Narasimhan M; Bank RL
    J Manag Care Spec Pharm; 2024 Jun; 30(6):549-559. PubMed ID: 38824623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [French Society for Biological Psychiatry and Neuropsychopharmacology task force: Formal Consensus for the prescription of depot antipsychotics].
    Samalin L; Abbar M; Courtet P; Guillaume S; Lancrenon S; Llorca PM
    Encephale; 2013 Dec; 39 Suppl 4():189-203. PubMed ID: 24373464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medication adherence and discontinuation of long-acting injectable versus oral antipsychotics in patients with schizophrenia or bipolar disorder.
    Greene M; Yan T; Chang E; Hartry A; Touya M; Broder MS
    J Med Econ; 2018 Feb; 21(2):127-134. PubMed ID: 28895758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment Patterns, Healthcare Resource Utilization and Costs Among Schizophrenia Patients Treated with Long-Acting Injectable Versus Oral Antipsychotics.
    Shah A; Xie L; Kariburyo F; Zhang Q; Gore M
    Adv Ther; 2018 Nov; 35(11):1994-2014. PubMed ID: 30269292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Impact of drug-reimbursement policies on prescribing: A case-study of a newly marketed long-acting injectable antipsychotic among relapsed schizophrenia patients".
    Jackson JW; Fulchino L; Rogers J; Mogun H; Polinski J; Henderson DC; Schneeweiss S; Fischer MA
    Pharmacoepidemiol Drug Saf; 2018 Jan; 27(1):95-104. PubMed ID: 29168261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of concomitant oral antipsychotic drug use among patients treated with long-acting, intramuscular, antipsychotic medications.
    Aggarwal NK; Sernyak MJ; Rosenheck RA
    J Clin Psychopharmacol; 2012 Jun; 32(3):323-8. PubMed ID: 22544006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Converting oral to long-acting injectable antipsychotics: a guide for the perplexed.
    Meyer JM
    CNS Spectr; 2017 Dec; 22(S1):14-28. PubMed ID: 29350127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of long-acting injectable antipsychotic prescription at discharge in patients with schizophrenia and other psychotic disorders.
    Şahin OŞ; Mursalova Z; Gadimov S; Üçok A
    Int Clin Psychopharmacol; 2021 Sep; 36(5):251-256. PubMed ID: 34310433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baseline results from the European non-interventional Antipsychotic Long acTing injection in schizOphrenia (ALTO) study.
    Llorca PM; Bobes J; Fleischhacker WW; Heres S; Moore N; Bent-Ennakhil N; Sapin C; Loze JY; Nylander AG; Patel MX
    Eur Psychiatry; 2018 Aug; 52():85-94. PubMed ID: 29734130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent Oral Antipsychotic Drug Use Among Schizophrenia Patients Initiated on Long-Acting Injectable Antipsychotics Post-Hospital Discharge.
    Doshi JA; Pettit AR; Stoddard JJ; Zummo J; Marcus SC
    J Clin Psychopharmacol; 2015 Aug; 35(4):442-6. PubMed ID: 26075492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A qualitative study of experiences with and perceptions regarding long-acting injectable antipsychotics: Part I-patient perspectives.
    Iyer S; Banks N; Roy MA; Tibbo P; Williams R; Manchanda R; Chue P; Malla A
    Can J Psychiatry; 2013 May; 58(5 Suppl 1):14S-22S. PubMed ID: 23945063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-Acting Injectable Antipsychotics: Where Do They Fit in the Treatment Plan?
    Correll CU; Lauriello J
    J Clin Psychiatry; 2018; 79(1):. PubMed ID: 29505193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-acting injectable antipsychotics for prevention and management of violent behaviour in psychotic patients.
    Mohr P; Knytl P; Voráčková V; Bravermanová A; Melicher T
    Int J Clin Pract; 2017 Sep; 71(9):. PubMed ID: 28869705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of switching to long-acting injectable antipsychotics on health services use in the treatment of schizophrenia.
    Lachaine J; Lapierre ME; Abdalla N; Rouleau A; Stip E
    Can J Psychiatry; 2015 Mar; 60(3 Suppl 2):S40-7. PubMed ID: 25886679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of SGA oral medications and a long-acting injectable SGA: the PROACTIVE study.
    Buckley PF; Schooler NR; Goff DC; Hsiao J; Kopelowicz A; Lauriello J; Manschreck T; Mendelowitz AJ; Miller del D; Severe JB; Wilson DR; Ames D; Bustillo J; Mintz J; Kane JM;
    Schizophr Bull; 2015 Mar; 41(2):449-59. PubMed ID: 24870446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of attitudes toward long-acting injectable antipsychotics among psychiatrists and patients.
    Kim SW; Lee YH; Jang JE; Yoo T; Kim JM; Shin IS; Yoon JS
    Int Clin Psychopharmacol; 2013 Mar; 28(2):80-6. PubMed ID: 23325306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying Predictors of Primary Adherence to Second Generation Long-Acting Injectable Antipsychotics Following Discharge from an Acute Inpatient Psychiatry Unit.
    Gilbert JL; Nelson LA; Kriz CR; Liu Y; Iuppa CA; Diefenderfer LA; Elliott ESR; Sommi RW
    Psychopharmacol Bull; 2019 Jun; 49(2):8-16. PubMed ID: 31308578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical determinants, patterns and outcomes of antipsychotic medication prescribing in the treatment of schizophrenia and schizoaffective disorder: A naturalistic cohort study.
    Groenendaal E; Lynch S; Dornbush R; Klepacz L; Ferrando S
    J Psychiatr Res; 2023 Feb; 158():273-280. PubMed ID: 36623361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.